There are 807 resources available
347P - Real-world efficacy of first-line therapy in wild-type non-small cell lung cancer (NSCLC) patients with brain metastases
Presenter: Benjamin Kong
Session: Poster viewing 05.
348P - Early interdisciplinary palliative care in patients with non-small cell lung cancer: A 24-weeks randomised controlled trial in Southwest China
Presenter: Nicole Chen
Session: Poster viewing 05.
349P - EXPLORE-LC: A multi-site real-world evidence research platform for non-small cell lung cancer in Asia-Pacific
Presenter: Kong Chian Toh
Session: Poster viewing 05.
350P - Primary prevention of chemotherapy-induced neutropenia in patients with advanced lung cancer in real-world research
Presenter: ZHEN ZENG
Session: Poster viewing 05.
351P - Real-world study of herombopag in primary prevention and treatment of chemotherapy-induced thrombocytopenia (CIT) in advanced lung cancer
Presenter: Haifeng Qin
Session: Poster viewing 05.
352P - Impact of novel agent therapy on survival of patients with advanced non-small cell lung cancer in Lebanon
Presenter: Marcel Massoud
Session: Poster viewing 05.
353P - Effect of cepharanthine on the stemness of lung squamous cell carcinoma based on network pharmacology and bioinformatics
Presenter: Jianxiong Deng
Session: Poster viewing 05.
354P - Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma
Presenter: jun deng
Session: Poster viewing 05.
355P - Anlotinib plus standard chemotherapy as first-line treatment in extensive-stage small cell lung cancer patients
Presenter: Wei Zhang
Session: Poster viewing 05.
356P - Efficacy and safety analysis of anlotinib and durvalumab plus chemotherapy in first-line therapy extensive-stage small cell lung cancer (SCLC)
Presenter: Lijuan Chen
Session: Poster viewing 05.